{"count": 249, "results": [{"_id": "37969650", "pmid": 37969650, "pmcid": "PMC10635887", "title": "The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy", "journal": "JACC CardioOncol", "authors": ["Onoue T", "Kang Y", "Lefebvre B", "Smith AM", "Denduluri S", "Carver J", "Fradley MG", "Chittams J", "Scherrer-Crosbie M"], "date": "2023-08-29T00:00:00Z", "doi": "10.1016/j.jaccao.2023.05.013", "meta_date_publication": "2023 Oct", "meta_volume": "5", "meta_issue": "5", "meta_pages": "674-682", "score": 50273.4, "text_hl": "None of the @SPECIES_9606 @@@patients@@@ who stopped taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ developed @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@.", "citations": {"NLM": "Onoue T, Kang Y, Lefebvre B, Smith AM, Denduluri S, Carver J, Fradley MG, Chittams J, Scherrer-Crosbie M. The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy JACC CardioOncol. 2023 Oct;5(5):674-682. PMID: 37969650", "BibTeX": "@article{37969650, title={The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy}, author={Onoue T and Kang Y and Lefebvre B and Smith AM and Denduluri S and Carver J and Fradley MG and Chittams J and Scherrer-Crosbie M}, journal={JACC CardioOncol}, volume={5}, number={5}, pages={674-682}}"}}, {"_id": "36088302", "pmid": 36088302, "pmcid": "PMC9464374", "title": "Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials", "journal": "BMC Cardiovasc Disord", "authors": ["Kamel AM", "Sabry N", "Farid S"], "date": "2022-09-10T00:00:00Z", "doi": "10.1186/s12872-022-02845-w", "meta_date_publication": "2022 Sep 10", "meta_volume": "22", "meta_issue": "1", "meta_pages": "405", "score": 50268.6, "text_hl": "Meta-regression analysis was used to assess the association of @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@ (@<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose, and duration with the SMCC.", "citations": {"NLM": "Kamel AM, Sabry N, Farid S. Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials BMC Cardiovasc Disord. 2022 Sep 10;22(1):405. PMID: 36088302", "BibTeX": "@article{36088302, title={Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials}, author={Kamel AM and Sabry N and Farid S}, journal={BMC Cardiovasc Disord}, volume={22}, number={1}, pages={405}}"}}, {"_id": "38107711", "pmid": 38107711, "pmcid": "PMC10719796", "title": "Metformin effects on cardiac parameters in non-diabetic Iraqi patients with heart failure and mid-range ejection fraction - a comparative two-arm parallel clinical study", "journal": "J Med Life", "authors": ["Sabbar R", "Kadhim SAA", "Fawzi HA", "Flayih A", "Mohammad B", "Swadi A"], "date": "2023-09-01T00:00:00Z", "doi": "10.25122/jml-2023-0253", "meta_date_publication": "2023 Sep", "meta_volume": "16", "meta_issue": "9", "meta_pages": "1400-1406", "score": 50264.93, "text_hl": "The mechanisms of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@ were the topic of two randomized clinical trials. ", "citations": {"NLM": "Sabbar R, Kadhim SAA, Fawzi HA, Flayih A, Mohammad B, Swadi A. Metformin effects on cardiac parameters in non-diabetic Iraqi patients with heart failure and mid-range ejection fraction - a comparative two-arm parallel clinical study J Med Life. 2023 Sep;16(9):1400-1406. PMID: 38107711", "BibTeX": "@article{38107711, title={Metformin effects on cardiac parameters in non-diabetic Iraqi patients with heart failure and mid-range ejection fraction - a comparative two-arm parallel clinical study}, author={Sabbar R and Kadhim SAA and Fawzi HA and Flayih A and Mohammad B and Swadi A}, journal={J Med Life}, volume={16}, number={9}, pages={1400-1406}}"}}, {"_id": "32758236", "pmid": 32758236, "pmcid": "PMC7409497", "title": "Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis", "journal": "Cardiovasc Diabetol", "authors": ["Halabi A", "Sen J", "Huynh Q", "Marwick TH"], "date": "2020-08-05T00:00:00Z", "doi": "10.1186/s12933-020-01100-w", "meta_date_publication": "2020 Aug 5", "meta_volume": "19", "meta_issue": "1", "meta_pages": "124", "score": 50264.465, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@", "citations": {"NLM": "Halabi A, Sen J, Huynh Q, Marwick TH. Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis Cardiovasc Diabetol. 2020 Aug 5;19(1):124. PMID: 32758236", "BibTeX": "@article{32758236, title={Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis}, author={Halabi A and Sen J and Huynh Q and Marwick TH}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={124}}"}}, {"_id": "35483800", "pmid": 35483800, "title": "Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.", "journal": "JACC Heart Fail", "authors": ["Tanaka A", "Node K"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.jchf.2022.02.012", "meta_date_publication": "2022 May", "meta_volume": "10", "meta_issue": "5", "meta_pages": "365-366", "score": 50263.277, "text_hl": "Revisited @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Heart Failure@@@ With Preserved Ejection Fraction.", "citations": {"NLM": "Tanaka A, Node K. Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2022 May;10(5):365-366. PMID: 35483800", "BibTeX": "@article{35483800, title={Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.}, author={Tanaka A and Node K}, journal={JACC Heart Fail}, volume={10}, number={5}, pages={365-366}}"}}, {"_id": "34944478", "pmid": 34944478, "pmcid": "PMC8698925", "title": "Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence", "journal": "Biomolecules", "authors": ["Salvatore T", "Galiero R", "Caturano A", "Vetrano E", "Rinaldi L", "Coviello F", "Di Martino A", "Albanese G", "Marfella R", "Sardu C", "Sasso FC"], "date": "2021-12-04T00:00:00Z", "doi": "10.3390/biom11121834", "meta_date_publication": "2021 Dec 4", "meta_volume": "11", "meta_issue": "12", "meta_pages": "", "score": 50263.223, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Heart Failure@@@: From Pathophysiological Rationale to Clinical Evidence", "citations": {"NLM": "Salvatore T, Galiero R, Caturano A, Vetrano E, Rinaldi L, Coviello F, Di Martino A, Albanese G, Marfella R, Sardu C, Sasso FC. Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence Biomolecules. 2021 Dec 4;11(12):. PMID: 34944478", "BibTeX": "@article{34944478, title={Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence}, author={Salvatore T and Galiero R and Caturano A and Vetrano E and Rinaldi L and Coviello F and Di Martino A and Albanese G and Marfella R and Sardu C and Sasso FC}, journal={Biomolecules}, volume={11}, number={12}}"}}, {"_id": "33167990", "pmid": 33167990, "pmcid": "PMC7654060", "title": "Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study", "journal": "Cardiovasc Diabetol", "authors": ["Chen TH", "Li YR", "Chen SW", "Lin YS", "Sun CC", "Chen DY", "Mao CT", "Wu M", "Chang CH", "Chu PH", "Wu VC"], "date": "2020-11-09T00:00:00Z", "doi": "10.1186/s12933-020-01169-3", "meta_date_publication": "2020 Nov 9", "meta_volume": "19", "meta_issue": "1", "meta_pages": "189", "score": 50263.062, "text_hl": "In @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, SGLT2i as first-line treatment may be associated with decreased events of @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@heart failure@@@ hospitalization, @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@acute coronary syndrome@@@, and all-cause mortality, compared with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as first-line treatment. ", "citations": {"NLM": "Chen TH, Li YR, Chen SW, Lin YS, Sun CC, Chen DY, Mao CT, Wu M, Chang CH, Chu PH, Wu VC. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study Cardiovasc Diabetol. 2020 Nov 9;19(1):189. PMID: 33167990", "BibTeX": "@article{33167990, title={Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study}, author={Chen TH and Li YR and Chen SW and Lin YS and Sun CC and Chen DY and Mao CT and Wu M and Chang CH and Chu PH and Wu VC}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={189}}"}}, {"_id": "35906276", "pmid": 35906276, "pmcid": "PMC9338272", "title": "Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)", "journal": "Sci Rep", "authors": ["Benes J", "Kotrc M", "Kroupova K", "Wohlfahrt P", "Kovar J", "Franekova J", "Hegarova M", "Hoskova L", "Hoskova E", "Pelikanova T", "Jarolim P", "Kautzner J", "Melenovsky V"], "date": "2022-07-29T00:00:00Z", "doi": "10.1038/s41598-022-17327-4", "meta_date_publication": "2022 Jul 29", "meta_volume": "12", "meta_issue": "1", "meta_pages": "13038", "score": 50262.207, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment is associated with improved outcome in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@advanced heart failure@@@ (@DISEASE_Heart_Failure_Systolic @DISEASE_MESH:D054143 @@@HFrEF@@@)", "citations": {"NLM": "Benes J, Kotrc M, Kroupova K, Wohlfahrt P, Kovar J, Franekova J, Hegarova M, Hoskova L, Hoskova E, Pelikanova T, Jarolim P, Kautzner J, Melenovsky V. Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF) Sci Rep. 2022 Jul 29;12(1):13038. PMID: 35906276", "BibTeX": "@article{35906276, title={Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)}, author={Benes J and Kotrc M and Kroupova K and Wohlfahrt P and Kovar J and Franekova J and Hegarova M and Hoskova L and Hoskova E and Pelikanova T and Jarolim P and Kautzner J and Melenovsky V}, journal={Sci Rep}, volume={12}, number={1}, pages={13038}}"}}, {"_id": "35483801", "pmid": 35483801, "title": "Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.", "journal": "JACC Heart Fail", "authors": ["Khan MS", "DeVore AD", "Felker GM", "Butler J", "Fonarow GC", "Greene SJ"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.jchf.2022.02.013", "meta_date_publication": "2022 May", "meta_volume": "10", "meta_issue": "5", "meta_pages": "366-367", "score": 50261.3, "text_hl": "Reply: Revisited @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@Heart Failure@@@ With Preserved Ejection Fraction.", "citations": {"NLM": "Khan MS, DeVore AD, Felker GM, Butler J, Fonarow GC, Greene SJ. Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2022 May;10(5):366-367. PMID: 35483801", "BibTeX": "@article{35483801, title={Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.}, author={Khan MS and DeVore AD and Felker GM and Butler J and Fonarow GC and Greene SJ}, journal={JACC Heart Fail}, volume={10}, number={5}, pages={366-367}}"}}, {"_id": "35322592", "pmid": 35322592, "pmcid": "PMC9065866", "title": "Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure", "journal": "ESC Heart Fail", "authors": ["Godec TR", "Bromage DI", "Pujades-Rodriguez M", "Cannatà A", "Gonzalez-Izquierdo A", "Denaxas S", "Hemingway H", "Shah AM", "Yellon DM", "McDonagh TA"], "date": "2022-06-01T00:00:00Z", "doi": "10.1002/ehf2.13910", "meta_date_publication": "2022 Jun", "meta_volume": "9", "meta_issue": "3", "meta_pages": "1608-1615", "score": 50260.95, "text_hl": "Numerous observational studies have reported beneficial outcomes of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@, including reductions in all-cause mortality and @<m>DISEASE_Heart_Failure</m> @DISEASE_MESH:D006333 @@@HF@@@ hospitalization. ", "citations": {"NLM": "Godec TR, Bromage DI, Pujades-Rodriguez M, Cannatà A, Gonzalez-Izquierdo A, Denaxas S, Hemingway H, Shah AM, Yellon DM, McDonagh TA. Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure ESC Heart Fail. 2022 Jun;9(3):1608-1615. PMID: 35322592", "BibTeX": "@article{35322592, title={Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure}, author={Godec TR and Bromage DI and Pujades-Rodriguez M and Cannatà A and Gonzalez-Izquierdo A and Denaxas S and Hemingway H and Shah AM and Yellon DM and McDonagh TA}, journal={ESC Heart Fail}, volume={9}, number={3}, pages={1608-1615}}"}}]}